4.7 Article

Synthesis and preliminary pharmacological evaluation of novel derivatives of L-β-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 16, Issue 16, Pages 7740-7748

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.07.001

Keywords

pharmacophore; bound conformation; diastereoselective; lipophilic pocket

Funding

  1. NCRR NIH HHS [RR15583, P20 RR015583] Funding Source: Medline
  2. NINDS NIH HHS [NS30570, NS045704, R01 NS030570, R01 NS045704-04, R01 NS045704, R01 NS030570-12] Funding Source: Medline

Ask authors/readers for more resources

A series of beta-benzylaspartate derivatives were prepared from N-trityl-L-aspartate dimethyl ester and evaluated as inhibitors of neuronal glutamate transporter EAAT3. The result of the structure-activity studies suggests that the position occupied by the aromatic ring of beta-benzylaspartate within the binding site of EAAT3 may be different from that occupied by comparable groups in previously identified inhibitors, such as L-threo-benzyloxy aspartate (TBOA). Further, halogen substitutions at the 3-postition of the aromatic ring of beta-benzylaspartate can increase the potency with which the analogues inhibit EAAT3. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available